Kirill Dmitriev, CEO of the Russian sovereign wealth fund RDIF and Special Envoy of the President of the Russian Federation for Investment and Economic Cooperation with Foreign Countries, has launched an account on https://t.co/40pqckxr26: @kadmitriev.

Kirill Dmitriev, CEO of RDIF, congratulates Magomed @AnkalaevM on winning the UFC 313 light heavyweight title and hopes for UFC events to return to Russia soon. #UFC313 #MMA #Russia More details: https://t.co/O81w82qABc

From Wall Street to Riyadh: Vladimir Putin’s dealmaker paved way for US-Russia talks. “I’ve historically always been in favour of developing the US-Russia relationship,” @kadmitriev said. More details: https://t.co/RgQCMSkyRW via @ft

The account will share news and insights on tackling global challenges and pursuing opportunities through enhanced economic cooperation with Russia.

Happy International Women's Day! Поздравляем с 8 Марта!

#RDIF today announced that the Ministry of Health of the Republic of #Kazakhstan has authorized the use of Sputnik M Russian vaccine for adolescents aged 12-17. Thus Kazakhstan has become the first country outside Russia to authorize the use of Sputnik M. @sputnikvaccine

This decision is another confirmation of the efficacy of mix & match approach pioneered by the Russian @sputnikvaccine in creating a stronger and more durable immunity, including against the Omicron variant.

Sputnik Light can become a major booster for those vaccinated with inactivated Chinese COVID vaccines globally after #China has officially recommended mix & match approach with adenoviral vector-based vaccines as boosters. @sputnikvaccine

The amount of investment in the project is estimated at approximately $200 mn.

#RDIF, JSC ER-Telecom Holding (@domru_ and https://t.co/AtTZzE1a4E Business trademarks) and Talos Fund I LP announce the start of construction of a new data center in Moscow, as a part of @Linxdatacenter's expansion and development of the leading cloud service in #Russia.

According to the interim results of the trials, involving 100 volunteers in Russia and 100 volunteers in Azerbaijan, the vaccines combination demonstrated an acceptable safety profile, which is consistent with the results of previous clinical trials. @AstraZeneca @sputnikvaccine

#RDIF, R-Pharm group and @AstraZeneca announce interim results of phase II clinical trials to evaluate the safety and immunogenicity of the combined use of AstraZeneca's vaccine and the first component of the @sputnikvaccine (Sputnik Light).

A number of countries, including #Argentina, #Bahrain, #UAE, San Marino and #Philippines, have already authorized Sputnik Light as a universal booster. @sputnikvaccine

#RDIF announces the Russian one-shot Sputnik Light vaccine against coronavirus has been authorized by the Drug Controller General of #India (DCGI). Thus Sputnik Light has been registered in more than 30 countries with total population of over 2.5 billion people. @sputnikvaccine

#RDIF announces that the Russian @sputnikvaccine against coronavirus has been granted full permanent approval by Russia’s Health Ministry. It had previously held temporary emergency use authorization (EUA) from the Russian regulator.

#RDIF, @AstraZeneca and Unicorn Capital Partners, a biotech-specialized VC fund, today announced the agreement to invest in Target Medicals, developing an inhibitor of aldosterone synthase, a key enzyme responsible for production of aldosterone.

#RDIF, Elbrus Capital Fund III and partners among the leading sovereign wealth funds of the Middle East today announced an investment in https://t.co/4yB3SUoPGp – the leading #Russian online hypermarket specializing in DIY tools and materials.

(3/3) An article by a team of 12 Italian and 9 Russian scientists led by Francesco Vaia, Director of the Spallanzani Institute and Alexander Gintsburg, Director of the Gamaleya Center, has been published in @medrxivpreprint and is available at: https://t.co/gLQqoydaVj

than 2 doses of @pfizer vaccine (2.1 times higher in total and 2.6 times higher 3 months after vaccination). The study demonstrates that @sputnikvaccine neutralizes the Omicron variant by inducing robust antibody response associated with high levels of protection. (2/3)

A unique comparative study conducted at the Italian Spallanzani Institute,by a team of researchers representing the Institute and the Gamaleya Center shows that the @sputnikvaccine demonstrates more than 2 times higher titers of virus neutralizing antibodies to Omicron (1/3)